Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 3 de 3
Article in English | Web of Science | ID: covidwho-1935260


Background Dexamethasone was the first intervention proven to reduce mortality in patients with COVID-19 being treated in hospital. We aimed to evaluate the adoption of corticosteroids in the treatment of COVID-19 in the UK after the RECOVERY trial publication on June 16, 2020, and to identify discrepancies in care. Methods We did an audit of clinical implementation of corticosteroids in a prospective, observational, cohort study in 237 UK acute care hospitals between March 16, 2020, and April 14, 2021, restricted to patients aged 18 years or older with proven or high likelihood of COVID-19, who received supplementary oxygen. The primary outcome was administration of dexamethasone, prednisolone, hydrocortisone, or methylprednisolone. This study is registered with ISRCTN, ISRCTN66726260. Findings Between June 17, 2020, and April 14, 2021, 47 795 (75.2%) of 63 525 of patients on supplementary oxygen received corticosteroids, higher among patients requiring critical care than in those who received ward care (11 185 [86.6%] of 12 909 vs 36 415 [72.4%] of 50 278). Patients 50 years or older were significantly less likely to receive corticosteroids than those younger than 50 years (adjusted odds ratio 0.79 [95% CI 0.70-0.89], p=0.0001, for 70-79 years;0.52 [0.46-0.58], p<0.0001, for >80 years), independent of patient demographics and illness severity. 84 (54.2%) of 155 pregnant women received corticosteroids. Rates of corticosteroid administration increased from 27.5% in the week before June 16, 2020, to 75-80% in January, 2021. Interpretation Implementation of corticosteroids into clinical practice in the UK for patients with COVID-19 has been successful, but not universal. Patients older than 70 years, independent of illness severity, chronic neurological disease, and dementia, were less likely to receive corticosteroids than those who were younger, as were pregnant women. This could reflect appropriate clinical decision making, but the possibility of inequitable access to life-saving care should be considered. Copyright (C) 2022 The Author(s). Published by Elsevier Ltd.

Age and Ageing ; 50(SUPPL 1), 2021.
Article in English | EMBASE | ID: covidwho-1254397


Introduction COVID-19 Trauma Guidance suggests opportunities for structured,time-limited discussions about challenging experiences should beoffered. It is unknown if such discussions can be effectivelydelivered online by palliative care specialists to support care home(CH) staff in relation to death/dying. Funded by Scotland's ChiefScientist Office COVID-19 “rapid research” fund, online OSCaRS isbeing piloted. Methods Fortnightly OSCaRS delivered to small groups of CH staff via asecure online platform in three local CHs over 10 weeks. Sessionsare digitally recorded. The shortened version of the Chesneycoping self-efficacy questionnaire is completed by all staffpre/post. Additional post-study questions asked of OSCaRSparticipants and in-depth staff interviews will be undertaken (n = 10). Thematic analysis of the recorded sessions and interviews willbe undertaken and related to the staff questionnaire and context of each CH. Results New learning on the feasibility and acceptability of providingOSCaRS to frontline staff. The benefit of OSCaRS to CH staff copingmechanisms, team cohesion and communicaton with relativesduring the COVID-19 pandemic will be presented. Initial results show that OSCaRS are feasible, valued by all care home staff and support staff in coping with the challenges of COVID-19/. Key Conclusions The analysis will inform future practice, and an ImplementationGuide for OSCaRS in CHs will be produced. Key learning on thepotential for online support in relation to death/dying during thepandemic and beyond will contribute to future education, trainingand staff wellbeing resources. It will also inform the role of suchsessions in developing individual coping mechanisms and teamworking alongside communication with relatives duringlockdown.

Age and Ageing ; 50(SUPPL 1), 2021.
Article in English | EMBASE | ID: covidwho-1254396


Introduction: COVID-19 in care homes has heightened the risk of staff burnout, undermining already problematic staff retention and low morale. There has been an associated proliferation of resources and online initiatives to support frontline workers, however, few of these are directly targeted at the care home workforce. Care home workers are highly skilled in caring for people with complex needs, but have very variable levels of formal training, and just over half of care homes in Scotland include registered nurses.This project will rapidly collate existing resources and identify, direct from care home workers, their best practice, initiatives, and resources used to support resilience and retention during this pandemic and moving forward. Methods: 1) Rapid review of care home specific evidence and resources (including published research and social media);2)Online survey of Enabling Research in CareHomes (ENRICH) members across Scotland (n=55);3) Case studies within six care homes to identify what is working well and what is not in terms of promoting resilience and emotional support. Results: The rapid review has identified a wide range of resources directed at supporting staff working in care homes;the survey and case studies will provide data on the key learning and resources that have supported staff, and outline the challenges identified. There are many resources available but staff do not access these. The role of the care home manager is key. Key conclusions: This comprehensive review of resources and initiatives will make a valuable contribution to policy and practice designed to reduce burnout and foster retention not just in care homes but more widely across health and social care.